mission: cure logo

Demonstrating a new model for curing disease

We are a coalition of doctors, researchers, patients, and entrepreneurs pioneering a new approach to curing diseases through innovative outcome-based financing. We collaborate with impact investors and payers to discover life-altering therapies and bring them to patients.

The first disease we are attacking is pancreatitis. The world’s top pancreatic experts believe a well-funded, coordinated research and development program could lead to effective treatments within 10 years. Mission: Cure is working to make that happen. Consulting with pancreatic experts from the nation’s top research and healthcare institutions, we developed a 10-year plan and are working to implement it.

OUR APPROACH

Financing Based On Patient Outcomes

a male scientist holds a pipette and puts liquid into small containers surroudned by beakers in a lab

Promising And Cost-Effective Methods To Cure Diseases

five business people sit around a laptop engaged in conversation

Active Collaboration Among Stakeholders

two people point and review a paper with bar and pie graphs

Partnerships With Impact Investors

The time is right to create a new model for curing disease.  Exciting developments in genetics and data are making precision medicine a reality. Healthcare payers are moving toward value-based funding, especially for chronic diseases.  And a new generation of impact investors—seeking to generate social and not just financial returns—have made curing disease a priority.

DONATE

We cannot do this without your support.

Donate

News from Mission: Cure

March 8, 2019 in Exocrine Pancreatic Insufficiency, News, Patient Resources, Topics, Webinars, Webinars: Exocrine Pancreatic Insufficiency (EPI) & Pancreatic Enzymes

Pancreatic Enzyme Replacement Therapy – New Information for Pancreatitis Patients on Treating EPI

Busting the Myths about Pancreatic Enzymes for Pancreatitis and EPI Dr. Steven Freedman, MD, Ph.D., a worldwide expert on pancreatic disease and cystic fibrosis, presents Busting the Myths about Pancreatic Enzymes for Pancreatitis. In this webinar, the fifth in Mission: Cure’s Patient and Family Webinar Series, Dr. Freedman explains: What causes exocrine pancreatic insufficiency (EPI)? How is EPI diagnosed and treated? When…
Read More
March 1, 2019 in News

Potential Chronic Pancreatitis Treatments Identified

On February 28, 2019, Rare Disease Day, an alliance of leading life-science companies, in partnership with Mission: Cure, announced the promising results of a 4-month "datathon" aimed at identifying potential treatments for chronic pancreatitis. Using artificial intelligence and statistical techniques, datathon participants identified 4 existing, approved drugs as repurposing candidates worth testing as possible cures for pancreatitis. New Pancreatitis Treatment…
Read More

Mission: Cure – Blog

March 25, 2019 in Blog, Exocrine Pancreatic Insufficiency, Patient Resources

EPI and Pancreatic Enzymes: Expert Doctor Answers Patient Questions

Dr. Steven Freedman of Beth Israel Deaconess Medical Center and Harvard Medical School Dr. Steven Freedman, MD, Ph.D., a worldwide expert on pancreatic disease and cystic fibrosis, presented on Mission: Cure’s Pancreatitis Patient Webinar on Exocrine Pancreatic Insufficiency (EPI) and Pancreatic Enzyme Replacement Therapy (PERT). EPI is one of the symptoms of pancreatitis. Pancreatic enzymes are a confusing but critically…
Read More
January 11, 2019 in Blog, Genetics, Patient Resources, Topics

Genetic Testing for Pancreatitis: What We Know Now

Dr. Mark Haupt, MD is the Chief Medical Officer of Ariel Precision Medicine, a company that provides digital health and genomics solutions for complex disorders, like pancreatitis. Dr. Haupt is a Pediatric Pulmonologist who has dedicated his career to helping patients with pancreatic disease through his work in academia, the pharmaceutical industry, and his current work with Ariel. As a…
Read More

Mission: Cure – Twitter